NasdaqGM:PVLABiotechs
Assessing Palvella Therapeutics (PVLA) Valuation After A Strong 1-Year Run And Recent Share Price Pullback
Event context and recent stock performance
Palvella Therapeutics (PVLA) has drawn fresh attention after recent trading saw the stock close at US$105.25. This move comes alongside a year-to-date gain of 5% and a 1-year total return near 3x.
See our latest analysis for Palvella Therapeutics.
Recent trading has been choppy, with the share price down 3.15% on the day, 6.52% over the past week and 25.94% over the past quarter. At the same time, the 1 year total shareholder return sits near 3x,...